St. Jude Medical, a US-based medical device company, has announced CE Mark approval of its next-generation Ellipse and SJM Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy ...
Tags: St.Jude Medical, Mark
Respicardia, a US-based implantable therapies developer, has received approval from the US Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) to begin the pivotal trial of remedē System. The trial will ...
Tags: Respicardia, therapies developer
Ventripoint Diagnostics has obtained CE mark certification from European notified body Intertek Semko for its NRV application for the VMS-2DE heart analysis system. The NRV database can be used in conjunction with right heart analysis ...
Tags: Ventripoint, CE Mark, NRV Application
Aastrom Biosciences has treated first patients in ixCELL-DCM Phase 2b trial of ixmyelocel-T in patients with advanced heart failure due to ischemic dilated cardiomyopathy (ischemic DCM). The trial is designed to assess the safety and ...
Tags: Aastrom, Ixcell-Dcm Phase 2B Trial
US based medical technology company Medtronic has introduced CardioGuide implant system in the US and Canada. The real-time navigation system is designed for determining the real-time location to place left-ventricular (LV) electrode lead ...
BioControl Medical has gained the US Food and Drug Administration approval to begin the third and largest phase of INOVATE-HF (INcrease Of VAgal TonE in Heart Failure), a global, multi-center, investigational device exemption (IDE) clinical ...
Tags: BioControl Medical, FDA, Medical
SynCardia Systems, a manufacturer of Total Artificial Heart, has secured $15m structured financing from Athyrium Opportunities Fund and $4m follow-on equity investment from existing shareholders. The company will use the capital to ...
Tags: SynCardia Systems, Artificial Heart, biventricular heart
Medtronic has submitted its investigational device exemption (IDE) application to the FDA to initiate a study of its Symplicity renal denervation system for the treatment of uncontrolled hypertension in patients with systolic blood pressure ...
Medtronic has obtained CE mark certification from the European Union for its Attain Performa portfolio of quadripolar leads. The quadripolar leads are compatible with the company's Viva/Brava Quad cardiac resynchronization therapy ...
Tags: Medtronic, CE mark certification, Attain Performa portfolio
CircuLite has obtained conditional approval from the US Food and Drug Administration (FDA) for its Synergy Circulatory Support System, designed for reversing the symptoms of heart failure in ambulatory chronic heart failure patients. The ...
Tags: CircuLite, FDA Conditional Approval, Micro-Blood Pump Device
Ventrix said that its VentriGel biomaterial scaffold has shown potential to prevent heart failure following heart attack in a pre-clinical study. VentriGel is injected in a minimally-invasive procedure using a catheter to repair damaged ...
Tags: Ventrix, heart attack, minimally invasive
Ilya Kurochkin is Professor and Head of the Laboratory of Postgenomic Chemistry in the Department of Chemistry at the Lomonsov Moscow State University. His research requires characterisation of size distribution, concentration and to ...
Tags: Ilya Kurochkin, Postgenomic Chemistry, Nanoparticle Tracking Analysis
Wireless remote monitoring devices will be used by more than 1.8 million people worldwide in four years, representing a six-fold increase in adoption of telehealth technology, according to a new study by InMedica, part of research firm IHS. ...
Medtronic has completed enrolling the first patient in MIRACLE EF clinical trial, designed to evaluate the effectiveness of its Consulta cardiac resynchronization therapy-pacemaker (CRT-P) in treating symptomatic heart failure patients with ...
Tags: Medtronic, MIRACLE EF, trial, CRT-P
If you think leaving the hospital means you're home for good, think again. About twenty percent of heart attack and pneumonia patients, and a quarter of heart failure patients, find themselves back in the hospital within 30 days, according ...
Tags: hospital, Medicare, Medicaid Services, hospital safety